These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 32417798

  • 1. Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease.
    Nonnekes J, Bloem BR.
    J Parkinsons Dis; 2020; 10(3):1245-1248. PubMed ID: 32417798
    [Abstract] [Full Text] [Related]

  • 2. Levodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease.
    Morales-Briceño H, Mahant N, Duma S, Martin A, Griffith J, Tsui D, Fung VS.
    Parkinsonism Relat Disord; 2019 Aug; 65():282-283. PubMed ID: 31221564
    [No Abstract] [Full Text] [Related]

  • 3. [A combined preparation stalevo in Parkinson's disease: a 5-year experience of continuous dopaminergic stimulation].
    Fedotova EIu, Karabanov AV, Poleshchuk VV, Polevaia EV, Mirkasimov AF, Zagorovskaia TB, Ivanova-Smolenskaia IA, Illarioshkin SN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012 Aug; 112(5):50-5. PubMed ID: 22951782
    [Abstract] [Full Text] [Related]

  • 4. Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Solla P, Cannas A, Marrosu MG, Marrosu F.
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1383-4. PubMed ID: 26453388
    [No Abstract] [Full Text] [Related]

  • 5. Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel.
    Marano M, Naranian T, di Biase L, Di Santo A, Poon YY, Arca R, Cossu G, Marano P, Di Lazzaro V, Fasano A.
    Parkinsonism Relat Disord; 2019 Dec; 69():140-146. PubMed ID: 31759188
    [Abstract] [Full Text] [Related]

  • 6. Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with "on" freezing of gait.
    Cossu G, Ricchi V, Pilleri M, Mancini F, Murgia D, Ricchieri G, Mereu A, Melis M, Antonini A.
    Neurol Sci; 2015 Sep; 36(9):1683-6. PubMed ID: 25939726
    [Abstract] [Full Text] [Related]

  • 7. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 8. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
    Facca A, Sanchez-Ramos J.
    Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153
    [No Abstract] [Full Text] [Related]

  • 9. Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.
    Politis M, Sauerbier A, Loane C, Pavese N, Martin A, Corcoran B, Brooks DJ, Ray-Chaudhuri K, Piccini P.
    Mov Disord; 2017 Feb; 32(2):235-240. PubMed ID: 27859651
    [Abstract] [Full Text] [Related]

  • 10. Initiating therapy for Parkinson's disease.
    Silver DE, Ruggieri S.
    Neurology; 1998 Jun; 50(6 Suppl 6):S18-22; discussion S44-8. PubMed ID: 9633682
    [Abstract] [Full Text] [Related]

  • 11. The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.
    Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, Mahoney SE, Gray DL, Mailman RB.
    J Parkinsons Dis; 2020 Jun; 10(4):1515-1527. PubMed ID: 32986682
    [Abstract] [Full Text] [Related]

  • 12. [High dosage therapy of Parkinson disease. New dopamine agonist pramipexol allows reduction of L-dopa dose down to zero].
    Arnold G, Kupsch A.
    Nervenarzt; 1999 Aug; 70(8):742-4. PubMed ID: 10483575
    [Abstract] [Full Text] [Related]

  • 13. [Prevention and treatment of fluctuations in patients with Parkinson's disease].
    Ludin HP, Surber Ch.
    Praxis (Bern 1994); 2006 Dec 20; 95(51-52):2013-8. PubMed ID: 17294589
    [Abstract] [Full Text] [Related]

  • 14. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.
    Med Lett Drugs Ther; 2015 Aug 03; 57(1474):112. PubMed ID: 26218794
    [No Abstract] [Full Text] [Related]

  • 15. Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease.
    Zibetti M, Angrisano S, Dematteis F, Artusi CA, Romagnolo A, Merola A, Lopiano L.
    J Neurol Sci; 2018 Feb 15; 385():105-108. PubMed ID: 29406886
    [Abstract] [Full Text] [Related]

  • 16. Levodopa-carbidopa intestinal gel is an option in Parkinson's disease with hyponatremia induced by dopamine agonists.
    Picillo M, Canoro V, Cicarelli G, Erro R, Barone P.
    Neurol Sci; 2020 Nov 15; 41(11):3361-3363. PubMed ID: 32506356
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.
    Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L.
    Eur J Neurol; 2019 Mar 15; 26(3):490-496. PubMed ID: 30347489
    [Abstract] [Full Text] [Related]

  • 18. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
    Block G, Liss C, Reines S, Irr J, Nibbelink D.
    Eur Neurol; 1997 Mar 15; 37(1):23-7. PubMed ID: 9018028
    [Abstract] [Full Text] [Related]

  • 19. Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson's Disease According to Analysis of Pump Data.
    Nyholm D, Adnan M, Senek M.
    J Parkinsons Dis; 2020 Mar 15; 10(4):1529-1534. PubMed ID: 32651335
    [Abstract] [Full Text] [Related]

  • 20. Freezing of gait and postural instability: the unpredictable response to levodopa in Parkinson's disease.
    Moreira F, Rebelo Gomes I, Januário C.
    BMJ Case Rep; 2019 Jul 22; 12(7):. PubMed ID: 31337633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.